NCT04469998View on ClinicalTrials.gov

Evaluation of AXR-270 for the Treatment of Posterior Blepharitis Associated With Meibomian Gland Dysfunction

PHASE2CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

June 16, 2020

Primary Completion Date

December 1, 2020

Study Completion Date

December 31, 2020

Conditions
Posterior BlepharitisMeibomian Gland Dysfunction
Interventions
DRUG

AXR-270 Low Dose

AXR-270 Topical Eyelid Cream

DRUG

AXR-270 High Dose

AXR-270 Topical Eyelid Cream

DRUG

AXR-270 Vehicle

AXR-270 Topical Eyelid Cream Vehicle

Trial Locations (1)

92008

AxeroVision, Inc., Carlsbad

Sponsors

Lead Sponsor

AxeroVision, Inc.
All Listed Sponsors
lead

AxeroVision, Inc.

INDUSTRY

NCT04469998 - Evaluation of AXR-270 for the Treatment of Posterior Blepharitis Associated With Meibomian Gland Dysfunction | Biotech Hunter | Biotech Hunter